You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD45RO antibody [UCHL1] (Phycoerythrin) (ab77217)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CD45RO antibody [UCHL1] (Phycoerythrin)
See all CD45RO products (9) ...

Description

Mouse monoclonal [UCHL1] to CD45RO (Phycoerythrin)

Conjugation

Phycoerythrin

Conjugation notes

The conjugate is purified by size exclusion chromatography and adjusted for direct use in flow cytometry.

Specificity

Recognizes CD45R0, a 180 kDa low molecular weight isoform of the leukocyte common antigen (LCA). The antigen is expressed on a subset of memory/activated T cells and on cortical thymocytes.

Tested applications

IP, IHC-P, IHC-Fr, Flow Cytmore details

Cross reactivity

Reacts with

Human

Immunogen

Human IL-2 dependent T cells

Positive control

Human blood cells; human tonsil tissue

Properties

Form

Liquid

Storage instructions

Store at +4°C in the dark. Do not freeze.

Storage buffer

Preservative: 15mM Sodium Azide
Constituents: 0.2% (w/v) high-grade protease free BSA, PBS

Concentration

Concentration information loading...

Purity

>95% by SDS-PAGE

Clonality

Monoclonal

Clone number

UCHL1

Isotype

IgG2a

Applications

Show applications key

Our Abpromise guarantee covers the use of ab77217 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IP

     
  • IHC-P

     
  • IHC-Fr

     
  • Flow Cyt

     

Application notes

Flow Cyt: Use 20 µl per 100 µl whole blood cells or 106 cells in suspension.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.

Involvement in disease

Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.

Sequence similarities

Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.

Domain

The first PTPase domain interacts with SKAP1.

Post-translational
modifications

Heavily N- and O-glycosylated.

Cellular localization

Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.

Target information above from: UniProt accessionP08575 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • B220 antibody
  • CD 45 antibody
  • CD45 antibody
  • cd45 antigen antibody
  • ec3.1.3.48 antibody
  • GP 180 antibody
  • GP180 antibody
  • Human homolog of severe combined immunodeficiency due to PTPRC deficiency antibody
  • L CA antibody
  • L-CA antibody
  • lca antibody
  • Leukocyte common antigen antibody
  • LY 5 antibody
  • LY5 antibody
  • Protein tyrosine phosphatase receptor type C antibody
  • Protein tyrosine phosphatase receptor type c polypeptide antibody
  • PTPRC antibody
  • PTPRC_HUMAN antibody
  • Receptor-type tyrosine-protein phosphatase C antibody
  • SCID due to PTPRC deficiency antibody
  • t200 antibody
  • T200 glycoprotein antibody
  • T200 leukocyte common antigen antibody
see all

References for Anti-CD45RO antibody [UCHL1] (Phycoerythrin) (ab77217)

This product has been referenced in:

  • Akbar AN  et al. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 140:2171-8 (1988).Read more (PubMed: 2965180) »
  • Terry LA  et al. The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology 64:331-6 (1988).Read more (PubMed: 2455685) »

See all 7 publications for this product

Publishing research using ab77217? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"